Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: Design and baseline characteristics of the Alpha Omega Trial

Follow-up of the patients was completed in November 2009, and findings will be reported in the second part of 2010.